Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Generic Drug Office Director Uhl Announces Retirement

Jul 18 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

CBER To Pause Receipt Of Lot Release Samples During Move To White Oak

Apr 14 2014

Generic Drugs 2014: OGD Creates Internal Review Goals, May Make OND-Inspired Changes

Jan 06 2014

Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions

Jun 04 2018

CDER Safety Overhaul Planned As Review Process Modernization Continues

Jul 09 2018

US FDA's Hiring: First Phase Of Cures Implementation Will Focus On Senior Staff

Jul 02 2018

GDUFA Success Story: FDA Exceeds Hiring Goals, Names OGD Director

Jan 15 2015

FDA Generic Office Director Uhl Returns From Medical Leave

Sep 21 2015

Additional Topics

United States FDA Generic Drugs Regulation Leadership BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window